• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无功能垂体腺瘤术后复发的列线图预测模型

Nomogram predictive model of post-operative recurrence in non-functioning pituitary adenoma.

作者信息

Lyu Wen, Fei Xu, Chen Cheng, Tang Yuqun

机构信息

Department of Neurosurgery, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University, Shenzhen, China.

Department of Neurosurgery, First Affiliated Hospital of Southern University of Science and Technology, Shenzhen, China.

出版信息

Gland Surg. 2021 Feb;10(2):807-815. doi: 10.21037/gs-21-47.

DOI:10.21037/gs-21-47
PMID:33708562
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7944052/
Abstract

BACKGROUND

To analyze and predict the possibility of post-operative recurrence in non-functioning pituitary adenoma (NFPA) patients, we investigated the clinical factors leading to tumor recurrence and built a nomogram predictive model based on these risk factors.

METHODS

A single-center retrospective study was performed. A total of 145 NFPA patients who underwent surgical treatment at Shenzhen People's Hospital from September 2013 to January 2019 were selected. Among them, 52 patients were diagnosed with recurrence of NFPA according to follow-up investigations. Binary logistic regression analysis was used to determine the significant risk factors. A nomogram model was then built to predict recurrence using these factors.

RESULTS

The univariate analysis and the binary logistic regression analysis showed that age, tumor size, cavernous invasion, sphenoid sinus invasion, and surgical extension were significant factors affecting tumor recurrence. We then built a nomogram model to predict post-operative recurrence in NFPA patients using these factors. The correlation analysis indicated that sphenoid sinus invasion [hazard ratio (HR) =13.14, 95% confidence interval (CI): 7.03-24.58, P<0.0001], cavernous sinus invasion (HR =7.53, 95% CI: 4.27-13.28, P<0.0001), and tumor size (HR =11.06, 95% CI: 6.11-20.03, P<0.0001) could promote the recurrence of NFPA. In contrast, advanced age (HR =0.50, 95% CI: 0.28-0.86, P<0.0001) and gross total resection (HR =0.12, 95% CI: 0.07-0.22, P<0.0001) could effectively inhibit recurrence.

CONCLUSIONS

In this study, we developed a nomogram predictive model based on the significant recurrence-associated factors for NFPA. This nomogram may aid neurosurgeons in the post-operative prediction of recurrence, and may facilitate tailored counseling of individual patients.

摘要

背景

为了分析和预测无功能垂体腺瘤(NFPA)患者术后复发的可能性,我们研究了导致肿瘤复发的临床因素,并基于这些危险因素建立了一个列线图预测模型。

方法

进行了一项单中心回顾性研究。选取了2013年9月至2019年1月在深圳市人民医院接受手术治疗的145例NFPA患者。其中,52例患者经随访调查诊断为NFPA复发。采用二元逻辑回归分析确定显著危险因素。然后使用这些因素建立列线图模型来预测复发。

结果

单因素分析和二元逻辑回归分析表明,年龄、肿瘤大小、海绵窦侵犯、蝶窦侵犯和手术范围是影响肿瘤复发的显著因素。然后,我们使用这些因素建立了一个列线图模型来预测NFPA患者的术后复发。相关性分析表明,蝶窦侵犯[风险比(HR)=13.14,95%置信区间(CI):7.03 - 24.58,P<0.0001]、海绵窦侵犯(HR =7.53,95%CI:4.27 - 13.28,P<0.0001)和肿瘤大小(HR =11.06,95%CI:6.11 - 20.03,P<0.0001)可促进NFPA复发。相反,高龄(HR =0.50,95%CI:0.28 - 0.86,P<0.0001)和全切(HR =0.12,95%CI:0.07 - 0.22,P<0.0001)可有效抑制复发。

结论

在本研究中,我们基于NFPA复发相关的显著因素开发了一个列线图预测模型。该列线图可能有助于神经外科医生对术后复发进行预测,并有助于为个体患者提供个性化的咨询。

相似文献

1
Nomogram predictive model of post-operative recurrence in non-functioning pituitary adenoma.无功能垂体腺瘤术后复发的列线图预测模型
Gland Surg. 2021 Feb;10(2):807-815. doi: 10.21037/gs-21-47.
2
Development and Validation of a Prognostic Model for Post-Operative Recurrence of Pituitary Adenomas.垂体腺瘤术后复发预后模型的建立与验证
Front Oncol. 2022 Apr 28;12:882049. doi: 10.3389/fonc.2022.882049. eCollection 2022.
3
Analysis of Related Factors of Tumor Recurrence or Progression After Transnasal Sphenoidal Surgical Treatment of Large and Giant Pituitary Adenomas and Establish a Nomogram to Predict Tumor Prognosis.经鼻蝶窦手术治疗大型和巨大型垂体腺瘤后肿瘤复发或进展的相关因素分析及建立预测肿瘤预后的列线图。
Front Endocrinol (Lausanne). 2021 Dec 14;12:793337. doi: 10.3389/fendo.2021.793337. eCollection 2021.
4
Endoscopic Endonasal Pituitary Surgery For Nonfunctioning Pituitary Adenomas: Long-Term Outcomes and Management of Recurrent Tumors.内镜经鼻蝶窦垂体瘤切除术治疗无功能垂体腺瘤:长期疗效及复发性肿瘤的处理。
World Neurosurg. 2021 Feb;146:e341-e350. doi: 10.1016/j.wneu.2020.10.083. Epub 2020 Oct 22.
5
Sphenoid sinus mucosal thickening in patients with non-functioning pituitary adenoma.蝶窦黏膜增厚与无功能垂体腺瘤。
Int J Clin Pract. 2021 Oct;75(10):e14604. doi: 10.1111/ijcp.14604. Epub 2021 Jul 14.
6
Therapeutic Strategy for Cavernous Sinus-Invading Non-Functioning Pituitary Adenomas Based on the Modified Knosp Grading System.基于改良Knosp分级系统的海绵窦侵袭性无功能垂体腺瘤的治疗策略
Brain Tumor Res Treat. 2016 Oct;4(2):63-69. doi: 10.14791/btrt.2016.4.2.63. Epub 2016 Oct 31.
7
Preoperative prediction of cavernous sinus invasion by pituitary adenomas using a radiomics method based on magnetic resonance images.基于磁共振图像的影像组学方法预测垂体腺瘤对海绵窦的侵袭
Eur Radiol. 2019 Mar;29(3):1625-1634. doi: 10.1007/s00330-018-5725-3. Epub 2018 Sep 25.
8
High-Field Intraoperative Magnetic Resonance Imaging Increases Extent of Resection and Progression-Free Survival for Nonfunctioning Pituitary Adenomas.高场术中磁共振成像增加无功能垂体腺瘤的切除范围和无进展生存期。
World Neurosurg. 2019 Jul;127:e925-e931. doi: 10.1016/j.wneu.2019.04.001. Epub 2019 Apr 8.
9
MRI radiomics for the prediction of recurrence in patients with clinically non-functioning pituitary macroadenomas.MRI 放射组学预测临床无功能性垂体大腺瘤患者的复发。
Comput Biol Med. 2020 Sep;124:103966. doi: 10.1016/j.compbiomed.2020.103966. Epub 2020 Aug 15.
10
Identifying critical protein-coding genes and long non-coding RNAs in non-functioning pituitary adenoma recurrence.识别无功能垂体腺瘤复发中的关键蛋白质编码基因和长链非编码RNA。
Oncol Lett. 2021 Apr;21(4):264. doi: 10.3892/ol.2021.12525. Epub 2021 Feb 8.

引用本文的文献

1
Predictors of progression after surgery in non-functioning pituitary macroadenomas: a Spanish multicenter study.无功能垂体大腺瘤术后进展的预测因素:一项西班牙多中心研究
J Endocrinol Invest. 2025 Aug 8. doi: 10.1007/s40618-025-02674-6.
2
MRI based radiomics nomogram for predict recurrence of non functioning pituitary macroadenomas post surgery.基于MRI的影像组学列线图预测无功能垂体大腺瘤术后复发情况
Sci Rep. 2025 Apr 14;15(1):12841. doi: 10.1038/s41598-025-89907-z.
3
Nomogram model for predicting medication adherence in patients with various mental disorders based on the Dryad database.基于 Dryad 数据库预测各种精神障碍患者用药依从性的列线图模型。
BMJ Open. 2024 Nov 14;14(11):e087312. doi: 10.1136/bmjopen-2024-087312.
4
Risk factor analysis and prediction model to establish recurrence or progression of non-functioning pituitary adenomas in men after transnasal sphenoidal surgery.经鼻蝶窦手术后男性无功能垂体腺瘤复发或进展的危险因素分析及预测模型的建立。
Sci Rep. 2024 Sep 16;14(1):21607. doi: 10.1038/s41598-024-72944-5.
5
Machine Learning Analysis of Post-Operative Tumour Progression in Non-Functioning Pituitary Neuroendocrine Tumours: A Pilot Study.无功能垂体神经内分泌肿瘤术后肿瘤进展的机器学习分析:一项试点研究
Cancers (Basel). 2024 Mar 19;16(6):1199. doi: 10.3390/cancers16061199.
6
Non-functioning pituitary macroadenoma following surgery: long-term outcomes and development of an optimal follow-up strategy.手术后无功能垂体大腺瘤:长期预后及最佳随访策略的制定
Front Surg. 2023 Jul 12;10:1129387. doi: 10.3389/fsurg.2023.1129387. eCollection 2023.
7
Preoperative Risk Stratification of Increased MIB-1 Labeling Index in Pituitary Adenoma: A Newly Proposed Prognostic Scoring System.垂体腺瘤中MIB-1标记指数升高的术前风险分层:一种新提出的预后评分系统。
J Clin Med. 2022 Dec 1;11(23):7151. doi: 10.3390/jcm11237151.
8
Prediction of Higher Ki-67 Index in Pituitary Adenomas by Pre- and Intra-Operative Clinical Characteristics.通过术前和术中临床特征预测垂体腺瘤中更高的Ki-67指数
Brain Sci. 2022 Jul 28;12(8):1002. doi: 10.3390/brainsci12081002.
9
Development and Validation of a Prognostic Model for Post-Operative Recurrence of Pituitary Adenomas.垂体腺瘤术后复发预后模型的建立与验证
Front Oncol. 2022 Apr 28;12:882049. doi: 10.3389/fonc.2022.882049. eCollection 2022.
10
Prognostic Factors for Recurrence in Pituitary Adenomas: Recent Progress and Future Directions.垂体腺瘤复发的预后因素:近期进展与未来方向
Diagnostics (Basel). 2022 Apr 13;12(4):977. doi: 10.3390/diagnostics12040977.

本文引用的文献

1
Predicting the likelihood of early recurrence based on mRNA sequencing of pituitary adenomas.基于垂体腺瘤的mRNA测序预测早期复发的可能性。
Gland Surg. 2019 Dec;8(6):648-656. doi: 10.21037/gs.2019.11.02.
2
Treatment of Pituitary and Other Tumours with Cabergoline: New Mechanisms and Potential Broader Applications.卡麦角林治疗垂体和其他肿瘤:新机制和潜在更广泛的应用。
Neuroendocrinology. 2020;110(6):477-488. doi: 10.1159/000504000. Epub 2019 Oct 10.
3
Predicting early post-operative remission in pituitary adenomas: evaluation of the modified knosp classification.预测垂体腺瘤术后早期缓解:改良 Knosp 分级评估。
Pituitary. 2019 Oct;22(5):467-475. doi: 10.1007/s11102-019-00976-6.
4
Immunohistochemical Study of NR2C2, BTG2, TBX19, and CDK2 Expression in 31 Paired Primary/Recurrent Nonfunctioning Pituitary Adenomas.31对原发性/复发性无功能垂体腺瘤中NR2C2、BTG2、TBX19和CDK2表达的免疫组织化学研究
Int J Endocrinol. 2019 May 16;2019:5731639. doi: 10.1155/2019/5731639. eCollection 2019.
5
PTTG overexpression in non-functioning pituitary adenomas: Correlation with invasiveness, female gender and younger age.生长转化基因在无功能垂体腺瘤中的过表达:与侵袭性、女性性别和年轻年龄的相关性。
Ann Diagn Pathol. 2019 Aug;41:83-89. doi: 10.1016/j.anndiagpath.2019.04.016. Epub 2019 May 2.
6
Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model.用统计学模型预测临床无功能垂体腺瘤的复发。
J Transl Med. 2019 May 20;17(1):164. doi: 10.1186/s12967-019-1915-2.
7
High-Field Intraoperative Magnetic Resonance Imaging Increases Extent of Resection and Progression-Free Survival for Nonfunctioning Pituitary Adenomas.高场术中磁共振成像增加无功能垂体腺瘤的切除范围和无进展生存期。
World Neurosurg. 2019 Jul;127:e925-e931. doi: 10.1016/j.wneu.2019.04.001. Epub 2019 Apr 8.
8
A two‑circRNA signature predicts tumour recurrence in clinical non‑functioning pituitary adenoma.双环状 RNA 特征可预测临床无功能垂体腺瘤的肿瘤复发。
Oncol Rep. 2019 Jan;41(1):113-124. doi: 10.3892/or.2018.6851. Epub 2018 Nov 2.
9
Cabergoline in the Management of Residual Nonfunctioning Pituitary Adenoma: A Single-Center, Open-Label, 2-Year Randomized Clinical Trial.卡麦角林治疗残留无功能性垂体腺瘤的单中心、开放标签、2 年随机临床试验。
Am J Clin Oncol. 2019 Feb;42(2):221-227. doi: 10.1097/COC.0000000000000505.
10
Nonfunctioning Pituitary Adenoma Recurrence and Its Relationship with Sex, Size, and Hormonal Immunohistochemical Profile.无功能垂体腺瘤复发及其与性别、大小和激素免疫组化特征的关系。
World Neurosurg. 2018 Dec;120:e241-e246. doi: 10.1016/j.wneu.2018.08.043. Epub 2018 Aug 20.